Clinical Trials
🇪🇺 EMA Page 10EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 109–120 of 139 articles
Boston Scientific Reports Strong Q1 2026 Growth with 10.9% US Sales Increase and Clinical Trial Breakthroughs
CervoMed's Neflamapimod Shows Brain Volume Increase in Dementia with Lewy Bodies Trial at AAN 2026
Celerion Secures Majority Investment from THL Partners to Expand Clinical Research Services
Veristat Acquires Certara's Regulatory Writing Business to Expand European Market Services
Polycythemia Vera Market Transformation: 9 Companies Including Protagonist Therapeutics with Rusfertide to Enter by 2036
European Research Revolution: Clinical Trial Tech Focus
EU BioPharma Clinical Trials: Key Oncology Data at ASCO & AUA
Kelun-Biotech's Sac-TMT Cancer Drug Selected for Three ASCO 2026 Oral Presentations
Eupraxia Pharmaceuticals Reports Positive 36-Week Data from Highest Dose Cohort in Eosinophilic Esophagitis RESOLVE Trial
Karyopharm Phase 3 SENTRY Trial Results Selected for ASCO 2026 Late-Breaking Presentation in Myelofibrosis
Allogene Therapeutics Expands Cemacabtagene Ansegedleucel Phase 2 ALPHA3 Trial to South Korea and Australia
EU vs US Clinical Trial Protocols: Key Differences in Design & Timelines